
Zyntex provides pharmaceutical-grade Moxifloxacin Hydrochloride. A broad-spectrum antibacterial agent ideal for respiratory tract and ocular infections.
Formulating effective antibiotic treatments for complex infections requires an API with high solubility and a consistent crystalline structure. Therefore, Zyntex supplies Moxifloxacin Hydrochloride that is specifically optimized for the production of film-coated tablets and sterile ophthalmic solutions. This compound is critical for managing community-acquired pneumonia, acute sinusitis, and chronic bronchitis. Specifically, it works perfectly for manufacturing once-daily dosage forms. Our production facility ensures that every batch complies strictly with USP, EP, and BP pharmacopeia standards.
The molecule is also a primary choice in the ophthalmic sector for treating bacterial conjunctivitis and preventing post-surgical eye infections. Moreover, it serves as a vital tool in combating resistant bacterial strains where other fluoroquinolones may show reduced efficacy. Zyntex utilizes advanced multi-stage synthesis and precision purification techniques to produce a pale yellow crystalline powder that is odorless and highly refined. Because we prioritize patient safety, our API undergoes rigorous testing to ensure zero microbial contamination in sterile-grade batches. Furthermore, our strict quality control measures ensure that heavy metal and impurity levels remain well below international safety limits.
Zyntex supports your pharmaceutical innovation with full technical transparency and comprehensive regulatory documentation. For instance, we provide detailed Certificates of Analysis (CoA) to verify the assay purity and the hydration state of the $C_{21}H_{24}FN_3O_4 \cdot HCl$ molecule. Thus, you can accelerate your product validation and simplify your internal quality assurance workflows. Partnering with Zyntex gives your brand a dependable foundation for clinical and surgical excellence. Finally, our global logistics network ensures that your bulk supplies arrive safely, securely, and on schedule.
This essential antibiotic agent is a cornerstone for the following medical sectors:
It acts as a primary active ingredient in medications for severe respiratory infections, including pneumonia and acute sinusitis.
Manufacturers use our sterile-grade API to produce eye drops that effectively treat bacterial conjunctivitis and protect ocular health.
Our API is ideal for formulating once-daily oral tablets, ensuring high patient compliance during antibiotic therapy.
It serves as a critical reference agent in studies focused on bacterial resistance and the development of new-generation anti-infectives.
| Parameter | Standard Value |
|---|---|
| CAS Number | 186826-86-8 |
| Assay (Purity) | 99.0% – 101.0% |
| Appearance | Pale Yellow Crystalline Powder |
| Compliance | USP / EP / BP |